Medical specialists from France tagged as investigators in clinical trials studying Ataxia

Total 45 results

Abi Warde Marie Thérèse, MD
Seen in:
- Strasbourg, CHRU de Strasbourg - Neurology/Pediatrics
Trials:
- NCT04261127 (Sub-Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Alexandra Durr, MD
Seen in:
- Paris, Département d'information médicale (DIM); Département de Biostatistique, Santn 3emé Publique et Information Médicale (BIOSPIM)- Bâtiment Mazarie étage; Hôpitaux Universitaires Pitié Salpêtrière
- Paris, Hopital Pitie Salpetriere
- Paris, Hôpital Pitié Salpêtrière, Bâtiment ICM
- Paris, Paris Brain Institute
- Paris, Pitie-Salpêtrière Hospital
Trials:
- NCT02069509 (Principal Investigator)
- NCT06016946 (Principal Investigator)
- NCT04297891 (Sub-Investigator)
- NCT01085227 (Sub-Investigator)
Conditions:
Alexis Brice, MD
Seen in:
- Paris, Pitie-Salpêtrière Hospital
Trials:
- NCT00140829 (Sub-Investigator)
Conditions:
- Cerebellar Ataxias;
- Spastic Paraplegias
Anheim Mathieu, MD PhD
Seen in:
- Strasbourg, CHRU de Strasbourg - Neurology/Pediatrics
Trials:
- NCT04261127 (Sub-Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Azulay Jean-Philippe, MD
Seen in:
- Marseille, CHU Marseille- Neurology
Trials:
- NCT04261127 (Principal Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Bereau Matthieu, MD
Seen in:
- Besançon, CHU de Besancon- Neurology
Trials:
- NCT04261127 (Principal Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Bertrand Fontaine, MD, PhD
Seen in:
- Paris, Pitie-Salpêtrière Hospital
Trials:
- NCT00140829 (Sub-Investigator)
Conditions:
- Cerebellar Ataxias;
- Spastic Paraplegias
Christel Thauvin, MD PhD
Seen in:
- Dijon, CHU de Dijon- Neurology
Trials:
- NCT04261127 (Sub-Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Christophe Verny, MD
Seen in:
- Angers, CHU d'Angers
Trials:
- NCT00140829 (Principal Investigator)
Conditions:
- Cerebellar Ataxias;
- Spastic Paraplegias
Cyril Goizet, MD, PhD
Seen in:
- Bordeaux, Hopital Pellegrin
Trials:
- NCT00140829 (Principal Investigator)
Conditions:
- Cerebellar Ataxias;
- Spastic Paraplegias
David Devos, MD
Seen in:
- Lille, CHU Lille- Neurology
Trials:
- NCT04261127 (Principal Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
De Saint Martin Anne, MD
Seen in:
- Strasbourg, CHRU de Strasbourg - Neurology/Pediatrics
Trials:
- NCT04261127 (Sub-Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Diana Rodriguez, MD
Seen in:
- Paris, Hôpital Armand Trousseau
Trials:
- NCT00140829 (Principal Investigator)
Conditions:
- Cerebellar Ataxias;
- Spastic Paraplegias
Didier Hannequin, MD, PhD
Seen in:
- Rouen, Hopital Charles Nicolle
Trials:
- NCT00140829 (Principal Investigator)
- NCT00149175 (Principal Investigator)
Conditions:
Eugénie MUTEZ, MD
Seen in:
- Lille, CHU Lille- Neurology
Trials:
- NCT04261127 (Sub-Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Fismand Solène, MD
Seen in:
- Nancy, CHU Nancy- Neurology
Trials:
- NCT04261127 (Sub-Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Gwendoline Dupont, MD
Seen in:
- Dijon, CHU de Dijon- Neurology
Trials:
- NCT04261127 (Sub-Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Iosif Andra Valentina, MD
Seen in:
- Strasbourg, CHRU de Strasbourg - Neurology/Pediatrics
Trials:
- NCT04261127 (Sub-Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Jean-Philippe Azulay, MD, PhD
Seen in:
- Marseille, Hopital de La Timone
Trials:
- NCT00140829 (Principal Investigator)
Conditions:
- Cerebellar Ataxias;
- Spastic Paraplegias
Karine N'Guyen, MD
Seen in:
- Marseille, Hopital de La Timone
Trials:
- NCT00140829 (Sub-Investigator)
Conditions:
- Cerebellar Ataxias;
- Spastic Paraplegias
Laugel Vincent, MD PhD
Seen in:
- Strasbourg, CHRU de Strasbourg - Neurology/Pediatrics
Trials:
- NCT04261127 (Sub-Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
laure PISELLA, PhD
Seen in:
- Bron, Centre de Recherche en Neuroscience de Lyon
- Bron, U1028 INSERM - CNRS UMR 5292 Equipe ImpAct
Trials:
- NCT03286686 (Principal Investigator)
- NCT04279158 (Principal Investigator)
Conditions:
Laurence Faivre, MD PhD
Seen in:
- Dijon, CHU de Dijon- Neurology
Trials:
- NCT04261127 (Sub-Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Marelli Cecilia, MD
Seen in:
- Montpellier, CHU Montpellier - Neurology
Trials:
- NCT04261127 (Principal Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Mathieu Anheim, MD
Seen in:
- Strasbourg, Hôpital de Hautepierre, Service de Neurologie
- Strasbourg, Hôptal de Hautepierre, Department of Neurology
- Strasbourg, SERVICE DE NEUROLOGIE Unité de Mouvements Anormaux/Centre expert Parkinson, CHU de Strasbourg, Hopital de Hautepierre
- Strasbourg, Service de neurologie, Hôpitaux Universitaires de Strasbourg
Trials:
- NCT02069509 (Principal Investigator)
- NCT03947216 (Principal Investigator)
- NCT06016946 (Principal Investigator)
- NCT05177809 (Principal Investigator)
Conditions:
Moreau Thibault, MD
Seen in:
- Dijon, CHU de Dijon- Neurology
Trials:
- NCT04261127 (Principal Investigator)
Conditions:
- Autosomal Recessive Cerebellar Ataxia
Odile Boespflug-Tanguy, MD, PhD
Seen in:
- Clermont-Ferrand, Hôpitaux de Clermont-Ferrand
Trials:
- NCT00140829 (Principal Investigator)
Conditions:
- Cerebellar Ataxias;
- Spastic Paraplegias

Clinical Trials on Ataxia

Cadent Therapeutics

Withdrawn

Study of CAD-1883 for Spinocerebellar Ataxia (Synchrony-1)

Spinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8 | Spinocerebellar Ataxia Type 17 | ARCA1 - Autosomal Recessive...

United States
Biohaven Pharmaceuticals, Inc.

Active, not recruiting

Troriluzole in Adult Subjects With Spinocerebellar Ataxia

Spinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8

United States, China
Assistance Publique - Hôpitaux de Paris

Completed

Biomarkers in Autosomal Dominant Cerebellar Ataxia (BIOSCA)

Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia, Autosomal Recessive 3 | Episodic Ataxia, Type 7

France
University of Chicago
Pfizer; Biogen; APDM Wearable Technologies

Active, not recruiting

Instrumented Data Exchange for Ataxia Study (IDEA)

Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6

United States
Biohaven Pharmaceuticals, Inc.

Active, not recruiting

Trial in Adult Subjects With Spinocerebellar Ataxia

Spinocerebellar Ataxias | Spinocerebellar Ataxia Genotype Type 1 | Spinocerebellar Ataxia Genotype Type 2 | Spinocerebellar Ataxia Genotype Type 3 | Spinocerebellar Ataxia Genotype Type 6 | Spinocerebellar Ataxia Genotype Type 7 | Spinocerebellar Ataxia Genotype Type 8 | Spinocerebellar Ataxia Genotype...

United States
University of California, Los Angeles
Rare Diseases Clinical Research Network; Office of Rare Diseases (ORD)

Completed

Characteristics of Episodic Ataxia Syndrome

Cerebellar Diseases | Episodic Ataxia Syndrome

United States, Canada, United Kingdom
Teachers College, Columbia University

Active, not recruiting

Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia (PRIME-Ataxia)

Spinocerebellar Ataxia Type 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 7

United States
Sclnow Biotechnology Co., Ltd.

Not yet recruiting

Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia

Spinocerebellar Ataxia Type 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6
University of California, Los Angeles

Active, not recruiting

Open Pilot Trial of BHV-4157

Spinocerebellar Ataxias | Spinocerebellar Ataxia 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | MSA-C

United States
Seoul National University Hospital

Completed

Effect of Nilotinib in Cerebellar Ataxia Patients

Ataxia, Cerebellar | Ataxia, Progressive

Korea, Republic of

Medical specialists from France tagged as investigators in clinical trials studying Ataxia

Clinical Trials on Ataxia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations